Meer dan Bio: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Meer dan Bio
Largest movements
- Tangible fixed assets -€2,150
down €2,150 (-1.4%), from €158,288 to €156,137
of which Other tangible fixed assets: -€1,963
- Profit (loss) carried forward -€4,401
down €4,401 (-2.0%), from -€218,478 to -€222,879
- Gross operating margin -€4,036
down €4,036, from €2,739 to -€1,297
- Other operating charges +€2,230
up €2,230 (+576%), from €387 to €2,617
- Depreciation +€152
up €152 (+423%), from €36 to €188
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €160,975 | €156,641 | -€4,333 | -2.7% |
| Fixed assets | 21/28 | €158,288 | €156,137 | -€2,150 | -1.4% |
| Tangible fixed assets | 22/27 | €158,288 | €156,137 | -€2,150 | -1.4% |
| Land and buildings | 22 | €3,721 | €3,533 | -€188 | -5.0% |
| Other tangible fixed assets | 26 | €154,567 | €152,604 | -€1,963 | -1.3% |
| Current assets | 29/58 | €2,687 | €504 | -€2,183 | -81.2% |
| Amounts receivable within one year | 40/41 | €605 | €66 | -€539 | -89.2% |
| Trade receivables | 40 | €605 | - | -€605 | |
| Other amounts receivable | 41 | - | €66 | +€66 | |
| Current investments | 50/53 | €250 | €250 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €1,772 | €189 | -€1,584 | -89.4% |
| Deferred charges and accrued income | 490/1 | €60 | - | -€60 | |
| Total equity and liabilities | 10/49 | €160,975 | €156,641 | -€4,333 | -2.7% |
| Equity | 10/15 | -€68,478 | -€72,879 | -€4,401 | -6.4% |
| Contributions | 10/11 | €150,000 | €150,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€218,478 | -€222,879 | -€4,401 | -2.0% |
| Amounts payable | 17/49 | €229,452 | €229,520 | +€68 | 0.0% |
| Amounts payable within one year | 42/48 | €229,452 | €229,520 | +€68 | 0.0% |
| Trade debts | 44 | €190 | €378 | +€188 | +99.2% |
| Suppliers | 440/4 | €190 | €378 | +€188 | +99.2% |
| Taxes, remuneration and social security | 45 | €720 | - | -€720 | |
| Taxes | 450/3 | €720 | - | -€720 | |
| Other amounts payable | 47/48 | €228,543 | €229,143 | +€600 | +0.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €36 | €188 | +€152 | +423% |
| Other operating charges | 640/8 | €387 | €2,617 | +€2,230 | +576% |
| Gross operating margin | 9900 | €2,739 | -€1,297 | -€4,036 | |
| Operating profit (loss) | 9901 | €2,316 | -€4,102 | -€6,418 | |
| Financial income | 75/76B | €7 | - | -€7 | |
| Recurring financial income | 75 | €7 | - | -€7 | |
| Financial charges | 65/66B | €282 | €299 | +€17 | +6.0% |
| Recurring financial charges | 65 | €282 | €299 | +€17 | +6.0% |
| Profit (loss) for the period before taxes | 9903 | €2,041 | -€4,401 | -€6,442 | |
| Profit (loss) for the period | 9904 | €2,041 | -€4,401 | -€6,442 | |
| Profit (loss) for the period to be appropriated | 9905 | €2,041 | -€4,401 | -€6,442 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.